Phase 3 Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Groupe Oncologie Radiotherapie Tete et Cou780 enrolled1 locationNCT07264075

Recruiting

Phase 2Phase 3

Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated Adjuvant RT in Head & Neck Malignancies

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

All India Institute of Medical Sciences369 enrolled1 locationNCT07573956